Takeda is establishing the capability to manufacture TAK-019 (known outside Japan as NVX-CoV2373) at its facilities in Japan and aims to begin distribution in the early calendar year 2022
The study is being carried out by the platform VISION (Vaccine Immunology Studies – Indian Outbreak-response Network) which includes top public and private research institutes.
The DGTR has recommended US $ 3.2 per kg and US $ 3.55 per kg duty on imports
Hetero’s drug is a biosimilar version of Roche’s Actemra/RoActemra and will be available at the end of this month
At present 18 per cent of the local pharmaceutical market is under government's price control
Union Minister addresses the 13th CII Global MedTech Summit on the sunrise medical devices sector in India
The Stasis connected care monitoring system includes - a bedside monitor that monitors 6 vital signs, a tablet that enables intuitive monitoring, and the Stasis app that allows for remote monitoring across devices
The drug has been granted permission by DCGI for emergency use as an adjunct therapy for Covid-19
_256_384.jpg)
As of June 30, 2021, 267 out of a total of 427 SEZs approved by the government are operational
_256_384.jpeg)
The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio
Subscribe To Our Newsletter & Stay Updated
